. Author manuscript; available in PMC: 2023 Aug 1.

Published in final edited form as: IEEE Trans Biomed Eng. 2022 Jul 20;69(8):2443–2455. doi: 10.1109/TBME.2022.3147066

TABLE I.

Subject demographics and characteristics

	All Subjects (n=20)	HFrEF Subjects (n=15)	HFpEF Subjects (n=5)	p-Value
Age, years	55 (46–64)	53 (45–62)	64 (64–66)	0.07
Sex				…
Male	16 (80%)	12 (80%)	4 (80%)
Female	4 (20%)	3 (20%)	1 (20%)
Height, cm	177 (168–181)	173 (168–180)	180 (175–183)	0.46
Weight, kg	93 (84–107)	92 (84–106)	93 (87–107)	0.93
BMI, kg/m²	31 (27–33)	31 (27–33)	28 (27–33)	0.86
Ejection fraction,%	24 (16–43)	21 (16–26)	58 (58–64)	0.001
NYHA class
I	1 (5%)	0 (0%)	1 (20%) 0
II	3 (15%)	3 (20%)	(0%)
III	11 (55%)	7 (47%)	4 (80%)
IV	5 (25%)	5 (33%)	0 (0%)
Systolic blood pressure, mmHg	115 (107–120)	110 (103–115)	120 (120–132)	0.008
Diastolic blood pressure, mmHg	68 (59–73)	70 (61–72)	64 (57–73)	0.76

Values shown are median (25^th-75^th percentiles) or n (% of the population) unless otherwise indicated. Statistical significance between HFrEF and HFpEF subjects in values, where applicable, was evaluated using a Mann-Whitney U test.; BMI, Body Mass Index; NYHA, New York Heart Association.